GM-CSF TREATMENT IN RECURRENT IMPLANTATION FAILURE WOMEN AFTER PGS: A RANDOMIZED CONTROLLED TRIAL

被引：0
|
作者：
Scarpellini, F. [1 ]
Sbracia, M. [2 ]
机构：
[1] CERM, Rome, Italy
[2] CERM, IVF Dept, Rome, Italy
来源：
HUMAN REPRODUCTION | 2019年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
O-126
引用
收藏
页码：56 / 56
页数：1
相关论文
共 50 条
  • [31] REVERSIBLE LEUKEMIC REGROWTH UNDER GM-CSF TREATMENT AFTER CHEMOTHERAPY FOR AML
    KOENIGSMANN, M
    HIDDEMANN, W
    BUCHNER, T
    LEUKEMIA RESEARCH, 1991, 15 (01) : 37 - 41
  • [32] Molgramostim (GM-CSF) associated with antibiotic treatment in nontraumatic abdominal sepsis - A randomized, double-blind, placebo-controlled clinical trial - Invited critique
    Harken, AH
    ARCHIVES OF SURGERY, 2006, 141 (02) : 154 - 154
  • [33] Prospective randomized clinical trial comparing high-dose ifosfamide + GM-CSF vs high-dose cyclophosphamide + GM-CSF for blood progenitor cell mobilization
    J Vela-Ojeda
    F Tripp-Villanueva
    L Montiel-Cervantes
    E Sánchez-Cortés
    M Ayala-Sánchez
    ME Guevara-Moreno
    LD García-León
    A Rosas-Cabral
    MA García-Ruiz Esparza
    J González-Llaven
    Bone Marrow Transplantation, 2000, 25 : 1141 - 1146
  • [34] Intralipid supplementation in women with unexplained recurrent implantation failure and elevated uterine natural killer cell levels - A randomized placebo controlled trial
    Dogra, Y.
    Singh, N.
    Mathur, S.
    HUMAN REPRODUCTION, 2021, 36 : 307 - 307
  • [35] TREATMENT OF A DELAYED GRAFT FAILURE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION WITH IL-3 AND GM-CSF
    VANNUCCHI, AM
    BOSI, A
    LASZLO, D
    GUIDI, S
    SACCARDI, R
    ROSSIFERRINI, P
    HAEMATOLOGICA, 1995, 80 (04) : 341 - 343
  • [36] USE OF GM-CSF (LEUKINE(R) SARGRAMOSTIM) AS A CHEMOPROTECTANT PRIOR TO IFOSFAMIDE, CARBOPLATIN, AND ETOPOSIDE - PRELIMINARY-RESULTS OF A RANDOMIZED, CONTROLLED TRIAL
    PERKINS, JB
    FIELDS, KK
    ELFENBEIN, GJ
    BALLESTER, OF
    GOLDSTEIN, SC
    HIEMENZ, JW
    ZORSKY, PE
    BLOOD, 1994, 84 (10) : A585 - A585
  • [37] Boosting immune response with GM-CSF optimizes primary cryotherapy outcomes in the treatment of prostate cancer: a prospective randomized clinical trial
    Barqawi, Al Baha
    Rodrigues Pessoa, Rodrigo
    Crawford, E. David
    Al-Musawi, Mohammed
    MacDermott, Tracey
    O'Donell, Colin
    Kendl, Ross M.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2021, 24 (03) : 750 - 757
  • [38] Boosting immune response with GM-CSF optimizes primary cryotherapy outcomes in the treatment of prostate cancer: a prospective randomized clinical trial
    Al Baha Barqawi
    Rodrigo Rodrigues Pessoa
    E. David Crawford
    Mohammed Al-Musawi
    Tracey MacDermott
    Colin O’Donell
    Ross M. Kendl
    Prostate Cancer and Prostatic Diseases, 2021, 24 : 750 - 757
  • [39] INTRALIPID FOR REPEATED IMPLANTATION FAILURE (RIF): A RANDOMIZED CONTROLLED TRIAL
    El-Khayat, W.
    El Sadek, M.
    FERTILITY AND STERILITY, 2015, 104 (03) : E26 - E26
  • [40] ENHANCED LYSIS OF HUMAN-MONOCYTES BY LAK CELLS AFTER TREATMENT WITH GM-CSF
    BLANCHARD, DK
    DJEU, JY
    LYMPHOKINE RESEARCH, 1988, 7 (03): : 334 - 334
12345